Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tiens Group, operating as Tianjin Tianshi Biological Development, is a global conglomerate specializing in biotechnology, health management, and retail. Founded in 1995 and headquartered in Tianjin, China, the company produces a wide range of wellness products, including dietary supplements, functional foods, and personal care items inspired by Traditional Chinese Medicine. Tiens utilizes a direct selling model to distribute its products across more than 190 countries. The company's flagship offerings focus on calcium supplementation and immune system support, supported by its large-scale manufacturing and R&D facility, the Tiens International Health Industrial Park. It remains one of the largest health-focused direct-selling enterprises in Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Tianshi Biological Development.